|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Net income from continuing operations | |||||
| Adjustments to reconcile net income from continuing operations to net cash flows provided by operating activities from continuing operations: | |||||
| Share-based compensation | |||||
| Depreciation and amortization | |||||
| Deferred income taxes | |||||
| Credit loss expense | |||||
| Non-cash lease expenses | |||||
| Amortization of deferred financing costs | |||||
| Accretion of asset retirement obligation | |||||
| Loss (gain) on fixed asset disposal | |||||
| Impairment of intangible assets | |||||
| Shares received in settlement of litigation | |||||
| Amortization of intangible assets | |||||
| Depreciation | |||||
| Other | |||||
| Increase (decrease) in cash resulting from changes in: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued compensation | |||||
| Accrued expenses | |||||
| Other liabilities | |||||
| Net cash flows from operating activities of continuing operations | |||||
| Net cash flows used in operating activities of discontinued operations | |||||
| Net cash flows provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Patent application costs | |||||
| Sales of equipment | |||||
| Cash paid for licensing agreement | |||||
| Patents and know-how | |||||
| Total cash paid for licensing agreement | |||||
| Principal payments from note receivable | |||||
| Cash paid for acquisitions | |||||
| Purchases of equipment | |||||
| Other investments | |||||
| Net cash flows used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Stock repurchased for tax withholdings on vesting of restricted stock | |||||
| Cash paid for Profit Share Payment (Note 14) | |||||
| Proceeds from Citizens Revolving Credit Facility | |||||
| Proceeds from Citizens Term Loan | |||||
| Prepayment premium on previous term loan | |||||
| Deferred financing cost | |||||
| Repayment of previous term loan | |||||
| Repayment of Citizens Revolving Credit Facility | |||||
| Principal payments on Citizens Term Loan Facility | |||||
| Proceeds from exercise of stock options | |||||
| Repurchase of Series B Preferred Shares | |||||
| Other | |||||
| Net cash flows used in financing activities | |||||
| Net change in cash | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
Loading...